comparemela.com

Nasal Nalmefene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma

LONDON (dpa-AFX) - Hikma Pharmaceuticals plc. (HIK, HIK.L) said Friday that it has not entered into any transaction with Opiant Pharmaceuticals (OPNT), contrary to a PR Newswire announcement issued

United kingdomCity ofHikma pharmaceuticalsOpiant pharmaceuticalsNasal nalmefeneUnited kingdom

Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release

/PRNewswire/ Opiant Pharmaceuticals (NASDAQ: OPNT) was the subject of a fake news release issued on Friday, April 29, 2022, that falsely stated Opiant.

United kingdomBen atkinsOpiant pharmaceuticals incOpiant pharmaceuticalsNasal nalmefeneInvestor inquiries

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

/PRNewswire/ Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire.

United arab emiratesUnited statesUnited kingdomCity ofPrnewswire hikma pharmaceuticalsOpiant pharmaceuticalsHikma pharmaceuticalsNasal nalmefeneMiddle eastNorth africaHikma pharmaceuticals plc

Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Correction statement re Opiant

Investegate announcements from Hikma Pharmaceutical, Correction statement re Opiant

United arab emiratesUnited statesUnited kingdomCity ofCamilla cunninghamSusan ringdalCharles armitsteadGlobal affairsOpiant pharmaceuticalsHikma pharmaceuticalsNasal nalmefeneStrategic planningInvestor relations managerRelations analystMiddle eastNorth africa

Hikma Pharmaceuticals PLC: Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

LONDON, April 29, 2022 /PRNewswire/ Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement

United arab emiratesUnited statesUnited kingdomCity ofPrnewswire hikma pharmaceuticalsOpiant pharmaceuticalsHikma pharmaceuticalsNasal nalmefeneMiddle eastNorth africa

vimarsana © 2020. All Rights Reserved.